Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | PLAU | P00749 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.43 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CTSD | P07339 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.38 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.38 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.38 |
| ▸ | CUL4A | Q13619 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6215287 | 0.86 | CYP1A2 (0.58) | CYP1A2ALDH1A1TSHRPLAUMAPT | |
| SCHEMBL6215281 | 0.86 | CYP1A2 (0.58) | CYP1A2ALDH1A1TSHRPLAUMAPT | |
| SCHEMBL1803059 | 0.81 | ALDH1A1 (0.67) | CYP1A2ALDH1A1TSHRMAPTCDK5 | |
| SCHEMBL3830559 | 0.80 | VCAM1 (0.50) | CYP1A2ALDH1A1TSHRMAPTHPGD | |
| SCHEMBL3207172 | 0.80 | S100A4 (0.37) | CYP1A2ALDH1A1PLAUMAPTMEN1 | |
| SCHEMBL3831033 | 0.80 | TDP1 (0.41) | MAPT | |
| SCHEMBL3836060 | 0.80 | TSHR (0.46) | ALDH1A1TSHRMAPTMEN1KMT2A | |
| SCHEMBL3829455 | 0.80 | TSHR (0.46) | ALDH1A1TSHRMAPTMEN1KMT2A | |
| SCHEMBL7677183 | 0.79 | ALDH1A1 (0.56) | CYP1A2ALDH1A1TSHRMAPTCDK5 | |
| SCHEMBL11341485 | 0.77 | CYP1A2 (0.54) | CYP1A2ALDH1A1TSHRPLAUMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110124668-A1 | NOVEL INDOLE DERIVATIVE HAVING, CARBAMOYL GROUP, UREIDO GROUP AND SUBSTITUTED OXY GROUP | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2011-05-26 | — | — | US | disclosed |
| EP-1432715-B1 | PYRIMIDINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2008-03-19 | — | — | EP | disclosed |
| US-7312224-B2 | Pyrimidine derivatives | MERCK PATENT GMBH (DE) | 2007-12-25 | — | — | US | disclosed |
| US-20040242595-A1 | Pyrimidine derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2004-12-02 | — | — | US | disclosed |
| EP-1432715-A2 | PYRIMIDINE DERIVATIVES | MERCK PATENT GmbH (DE) | 2004-06-30 | — | — | EP | disclosed |
| WO-2003031447-A2 | PYRIMIDINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2003-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124668-A1 | NOVEL INDOLE DERIVATIVE HAVING, CARBAMOYL GROUP, UREIDO GROUP AND SUBSTITUTED OXY GROUP | IKBKB, CHUK, RELA | CYP1A2 3047/4885ALDH1A1 2063/4885TSHR 2214/4885 |
| US-20040242595-A1 | Pyrimidine derivatives | TYMP, DPYD, TYMS | CYP1A2 361/4885ALDH1A1 671/4885TSHR 1636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.